Helix BioPharma Corp.

OTCPK:HBPC.F Stock Report

Market Cap: US$31.9m

Helix BioPharma Management

Management criteria checks 1/4

Helix BioPharma's CEO is Jacek Antas, appointed in Dec 2022, has a tenure of 1.33 years. total yearly compensation is CA$267.28K, comprised of 24.3% salary and 75.7% bonuses, including company stock and options. directly owns 1.39% of the company’s shares, worth $443.06K. The average tenure of the management team and the board of directors is 0.3 years and 1.3 years respectively.

Key information

Jacek Antas

Chief executive officer

CA$267.3k

Total compensation

CEO salary percentage24.3%
CEO tenure1.3yrs
CEO ownership1.4%
Management average tenureless than a year
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jacek Antas's remuneration changed compared to Helix BioPharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2023n/an/a

-CA$6m

Jul 31 2023CA$267kCA$65k

-CA$6m

Compensation vs Market: Jacek's total compensation ($USD195.28K) is below average for companies of similar size in the US market ($USD667.11K).

Compensation vs Earnings: Insufficient data to compare Jacek's compensation with company performance.


CEO

Jacek Antas

1.3yrs

Tenure

CA$267,278

Compensation

Mr. Jacek Antas serves as Chief Executive Officer and Director of Helix BioPharma Corp. since December 08, 2022 and serves as its Chairman. He serves as a Director of Helix BioPharma Corp. since April 18,...


Leadership Team

NamePositionTenureCompensationOwnership
Jacek Antas
Chairman & CEO1.3yrsCA$267.28k1.39%
CA$ 443.1k
Praveen Varshney
CFO & Corporate Secretaryless than a yearno datano data
Gabrielle Siegers
Head of R&D1.6yrsno datano data
Srikanth Sola
Chief Strategy Officerless than a yearno datano data
Christof Boehler
Chief Business Development Officerless than a yearno datano data

0.3yrs

Average Tenure

Experienced Management: HBPC.F's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jacek Antas
Chairman & CEO2yrsCA$267.28k1.39%
CA$ 443.1k
Jerzy Leszczynski
Independent Director2yrsno data0.91%
CA$ 289.2k
Malgorzata Laube
Independent Director1.3yrsno datano data
Janusz Grabski
Independent Directorless than a yearno datano data
Margaret Laube
Independent Director1.3yrsno datano data

1.3yrs

Average Tenure

Experienced Board: HBPC.F's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.